参考文献/References:
[1] SUNG H, FERLAY J, SIEGEL RL, et al. Global cancerstatistics 2020: GLOBOCAN estimates of incidenceand mortality worldwide for 36 cancers in 185countries[J]. CAA Cancer J Clin. 2021 ,71(3):209-249.
[2] 席俊峰, 彭彦才, 马兴聪, 等.Aurora-B 激酶的表达与非小细胞肺癌患者预后及耐药的相关性分析[J].现代检验医学杂志,2020,35(6):59-63.XI Junfeng, PENG Yancai, MA Xingcong, et al.Study on the relationship between high expression ofAurora-B kinase and drug resistance and prognosis inpatients with non-smell cell lung cancer[J]. Journal ofModern Laboratory Medicine,2020,35(6):59-63.
[3] BADE B C, DELA CRUZ C S. Lung cancer 2020:epidemiology, etiology, and prevention[J]. Clinics inChest Medicine, 2020, 41(1):1-24.
[4] JOS? RANIERY F J, KOENIGKAM-SANTOS M,CIPRIANO F E G, et al. Radiomics-based features forpattern recognition of lung cancer histopathology andmetastases[J]. Computer Methods and Programs inBiomedicine, 2018, 159:23-30.
[5] XIE Liangqun, HUANG Jinghui, DAI Lei, et al. Lossof-function plays a major role in early neurogenesis oftubulin α-1 A (TUBA1A) mutation-related brain malformations[J]. Mol Neurobiol, 2021,58(4):1291-1302.
[6] WANG C N, LI Li , CAI Yidong, et al. Identificationof prognostic candidate genes in breast cancer byintegrated bioinformatic analysis[J]. Journal of ClinicalMedicine, 2019, 8(8):1160.
[7] BIAN Tingting, ZHENG Miaosen, JIANG Daishan,et al. Prognostic biomarker TUBA1C is correlated toimmune cell infiltration in the tumor microenvironmentof lung adenocarcinoma[J]. Cancer Cell Int, 2021,21(1):144.
[8] YANG Jianru, JIA Yang, WANG Bing, et al. CircularRNA TUBA1C accelerates the progression of nonsmall-cell lung cancer by sponging miR-143-3p[J].Cellular Signalling, 2020, 74:109693.
[9] 闫小妮, 田国祥, 潘振宇, 等. 如何挖掘GEPIA 数据库中研究数据并生成分析结果表达图[J]. 中国循证心血管医学杂志,2019,11(5):521-525.YAN Xiaoni, TIAN Guoxiang, PAN Zhenyu, et al. Howto research data in the GEPIA database and generate ananalysis result graph[J]. Chinese Journal of Evidence-Based Cardiovascular Medicine,2019,11(5):521-525.
[10] WU P , HEINS Z J , MULLER J T , et al. Integrationand analysis of CPTAC proteomics data in the contextof cancer genomics in the cBioPortal[J]. Mol CellProteomics, 2019, 18(9):1893-1898.
[11] BUECHNER P, HINDERER M, UNBERATH P,et al. Requirements analysis and specification for amolecular tumor board platform based on cBioPortal[J].Diagnostics, 2020, 10(2):93.
[12] 黄刚, 陈霏, 肇玉博, 等. 非小细胞肺癌患者血浆miRNA-145 和miRNA-221 表达与临床特征及术后复发的相关性研究[J]. 现代检验医学杂志, 2019, 34(4):40-44.HUANG Gang, CHEN Fei, ZHAO Yubo, et al.Study on the correlation between the expression ofmiRNA-145 and miRNA-221 in plasma and clinicalcharacteristics and PDS toperative recurrence inpatients with non-small cell lung cancer [J]. Journal ofMedern Laboratory Medicine,2019,34(4):40-44.
[13] SUN Chengcao, LI Shujun, HU We i , e t a l .Comprehensive analysis of the expression andprognosis for E2Fs in human breast cancer[J]. MolTher, 2019, 27(6):1153-1165.
[14] MCNAIR C, XU Kexin, MANDIGO A C, etal. Differential impact of RB status on E2F1reprogramming in human cancer[J]. J Clin Invest,2018,128(1):341-358.
[15] YANG Cheng, DONG Zhitao, HONG Han, et al.CircFN1 mediates sorafenib resistance of hepatocellularcarcinoma cells by sponging miR-1205 and regulatingE2F1 expression[J]. Molecular Therapy - NucleicAcids, 2020,22:421-433.
[16] HE Jiang, ZHAO Yuzu, ZHAO Erhu, et al. Cancertestisspecific gene OIP5: A downstream gene ofE2F1 that promotes tumorigenesis and metastasis inglioblastoma by stabilizing E2F1 signalling[J]. NeuroOncology, 2018, 20(9):1173-1184.
[17] REN Xiaofan, CHEN Changhao, LUO Yuming, etal. lncRNA-PLACT1 sustains activation of NF-κBpathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer[J]. Mol Cancer, 2020,19(1):35.
[18] ROCCA M S, BENNA C, MOCELLIN S, et al. E2F1germline copy number variations and melanomasusceptibility[J]. J Transl Med, 2019, 17(1):181.
[19] CHEN Hao, CHEN Jun, ZHAO Long, et al. CDCA5,transcribed by E2F1, promotes oncogenesis byenhancing cell proliferation and inhibiting apoptosisvia the AKT pathway in hepatocellular carcinoma[J].Journal of Cancer, 2019, 10(8):1846-1854.
[20] MADDEN S K, De ARAUJO A D, GERHARDT M,et al. Taking the Myc out of cancer: toward therapeuticstrategies to directly inhibit c-Myc[J]. MolecularCancer, 2021, 20(1):3.
[21] ZHANG Yangyang, DONG Fan. Gfi1 upregulatesc-Myc expression and promotes c-Myc-driven cellproliferation[J]. Scientific Reports, 2020, 10(1):17115.
[22] SANTORO A, VLACHOU T, LUZI L, et al. p53 lossin breast cancer leads to myc activation, increased cellplasticity, and expression of a mitotic signature withprognostic value[J]. Cell Reports, 2019, 26(3):624-638.
[23] LI Haoyan, FANG Yanjia, NIU Chunyi, et al. From theCoverPNAS Plus: Inhibition of cIAP1 as a strategy fortargeting c-MYC–driven oncogenic activity[J]. ProcNati Acad Sci U S A, 2018, 115(40):E9317-E9324.
[24] MICHELLE L L, EDWARDS M C, MEYERS Z R, etal. Replication study: transcriptional amplification intumor cells with elevated c-Myc[J]. 2018, 7:e30274.
[25] CARROLL P A, FREIE B W, MATHSYARAJA H, etal. The MYC transcription factor network: Balancingmetabolism, proliferation and oncogenesis[J]. FrontMed, 2018, 12(4):412-425.
相似文献/References:
[1]刘 欣,张欢欢,关 平,等.肺腺癌细胞中长链非编码 RNA- ARAP1-AS1 表达模式及其生物学特征[J].现代检验医学杂志,2021,36(03):38.[doi:10.3969/j.issn.1671-7414.2021.03.009]
LIU Xin,ZHANG Huan-huan,GUAN Ping,et al.Expression Pattern and Biological Characteristics of ARAP1-AS1 in LungAdenocarcinoma Cells[J].Journal of Modern Laboratory Medicine,2021,36(04):38.[doi:10.3969/j.issn.1671-7414.2021.03.009]
[2]胡艳正,牛彦杰,石鹏飞.长链非编码RNA LINC00222对肺腺癌细胞增殖、迁移、侵袭和凋亡的影响及作用机制的研究[J].现代检验医学杂志,2021,36(05):16.[doi:10.3969/j.issn.1671-7414.2021.05.004]
HU Yan-zheng,NIU Yan-jie,SHI Peng-fei.Effect of Long Non Coding RNA LINC00222 on Proliferation, Migration,Invasion and Apoptosis of Lung Adenocarcinoma Cells and Its Mechanism[J].Journal of Modern Laboratory Medicine,2021,36(04):16.[doi:10.3969/j.issn.1671-7414.2021.05.004]
[3]鲍培龙,徐月亮,王孝彬.miR-153对肺腺癌细胞增殖、侵袭、迁移和凋亡的影响及机制研究[J].现代检验医学杂志,2022,37(01):107.[doi:10.3969/j.issn.1671-7414.2022.01.022]
BAO Pei-long,XU Yue-liang,WANG Xiao-bin.Effects of miR-153 on Proliferation, Invasion, Metastasis and Apoptosis of Lung Adenocarcinoma Cells and Its Mechanism[J].Journal of Modern Laboratory Medicine,2022,37(04):107.[doi:10.3969/j.issn.1671-7414.2022.01.022]
[4]董胜鉴,黄丽丽,李树锦.肺腺癌患者血清中miR-498，miR-339-5p和miR-210-3p水平表达的临床诊断价值[J].现代检验医学杂志,2022,37(02):58.[doi:10.3969/j.issn.1671-7414.2022.02.012]
DONG Sheng- jian,HUANG Li- li,LI Shu -jin.Clinical Diagnostic Value Expressed at miR-498, miR-339-5p and miR-210-3p Levels in Serum in Patients with Lung Adenocarcinoma[J].Journal of Modern Laboratory Medicine,2022,37(04):58.[doi:10.3969/j.issn.1671-7414.2022.02.012]
[5]苗 毅a,杨淑梅a,王 晶b,等.肺腺癌组织中MCM4 的表达及其与预后、免疫微环境的相关性分析[J].现代检验医学杂志,2023,38(05):115.[doi:10.3969/j.issn.1671-7414.2023.05.022]
MIAO Yia,YANG Shumeia,WANG Jingb,et al.Expression of MCM4 in Lung Adenocarcinoma and Its Correlation with Prognosis and Immune Microenvironment[J].Journal of Modern Laboratory Medicine,2023,38(04):115.[doi:10.3969/j.issn.1671-7414.2023.05.022]